Cambridge Investment Research Advisors’s Pacer Emerging Markets Cash Cows 100 ETF ECOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
38,532
+5,425
+16% +$149K ﹤0.01% 2301
2026
Q1
$883K Buy
33,107
+6,768
+26% +$179K ﹤0.01% 2283
2025
Q4
$643K Buy
26,339
+2,031
+8% +$50.5K ﹤0.01% 2486
2025
Q3
$594K Buy
24,308
+13,085
+117% +$304K ﹤0.01% 2512
2025
Q2
$248K Buy
+11,223
New +$234K ﹤0.01% 3142
2024
Q4
Sell
-28,512
Closed -$623K 3505
2024
Q3
$623K Sell
28,512
-1,923
-6% -$39.3K ﹤0.01% 2233
2024
Q2
$617K Buy
30,435
+135
+0.4% +$2.83K ﹤0.01% 2121
2024
Q1
$609K Buy
30,300
+3,671
+14% +$72.3K ﹤0.01% 2104
2023
Q4
$537K Sell
26,629
-2,990
-10% -$56.6K ﹤0.01% 2125
2023
Q3
$568K Buy
+29,619
New +$588K ﹤0.01% 1982

Other funds holding ECOW

Cambridge Investment Research Advisors's ECOW Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Pacer Emerging Markets Cash Cows 100 ETF (ECOW) stake by 16% in Q2 2026, buying an estimated $149K and bringing the position to 38,532 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2301.

Cambridge Investment Research Advisors first reported a position in ECOW in Q3 2023 and has held it in 10 quarters since. 62 funds tracked by Wall St. Rank hold ECOW as of Q2 2026.

  • Cambridge Investment Research Advisors held 38,532 shares of Pacer Emerging Markets Cash Cows 100 ETF worth $1.02M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 5,425 Pacer Emerging Markets Cash Cows 100 ETF shares in Q2 2026, an estimated $149K.
  • Pacer Emerging Markets Cash Cows 100 ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2301 holding.
  • Cambridge Investment Research Advisors first reported a position in Pacer Emerging Markets Cash Cows 100 ETF in Q3 2023 and has held it in 10 quarters since.
  • 62 funds tracked by Wall St. Rank held Pacer Emerging Markets Cash Cows 100 ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.